197 related articles for article (PubMed ID: 29569320)
1. Primary magnetic resonance imaging/ultrasonography fusion-guided biopsy of the prostate.
Maxeiner A; Kittner B; Blobel C; Wiemer L; Hofbauer SL; Fischer T; Asbach P; Haas M; Penzkofer T; Fuller F; Miller K; Cash H
BJU Int; 2018 Aug; 122(2):211-218. PubMed ID: 29569320
[TBL] [Abstract][Full Text] [Related]
2. Targeted multiparametric magnetic resonance imaging/transrectal ultrasound-guided (mpMRI/TRUS) fusion prostate biopsy versus systematic random prostate biopsy: A comparative real-life study.
Pham THN; Schulze-Hagen MF; Rahnama'i MS
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1962. PubMed ID: 38217298
[TBL] [Abstract][Full Text] [Related]
3. Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy.
Hansen NL; Kesch C; Barrett T; Koo B; Radtke JP; Bonekamp D; Schlemmer HP; Warren AY; Wieczorek K; Hohenfellner M; Kastner C; Hadaschik B
BJU Int; 2017 Nov; 120(5):631-638. PubMed ID: 27862869
[TBL] [Abstract][Full Text] [Related]
4. Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer.
Hansen NL; Barrett T; Kesch C; Pepdjonovic L; Bonekamp D; O'Sullivan R; Distler F; Warren A; Samel C; Hadaschik B; Grummet J; Kastner C
BJU Int; 2018 Jul; 122(1):40-49. PubMed ID: 29024425
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Magnetic Resonance Imaging/Ultrasound-guided Target Biopsy in Detecting Clinically Significant Prostate Cancer.
Kurokawa G; Mori K; Sasaki H; Nakano J; Takahashi Y; Iwatani K; Urabe F; Tsuzuki S; Koike Y; Sato S; Takahashi H; Miki K; Kimura T
Anticancer Res; 2024 Feb; 44(2):679-686. PubMed ID: 38307559
[TBL] [Abstract][Full Text] [Related]
6. Growth Patterns of Prostate Cancers Undetected by Prostate 3T Multiparametric MRI.
Chang KP; Hsieh PF; Lin WC; Chang H
In Vivo; 2024; 38(2):833-841. PubMed ID: 38418107
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial.
Simmons LAM; Kanthabalan A; Arya M; Briggs T; Barratt D; Charman SC; Freeman A; Hawkes D; Hu Y; Jameson C; McCartan N; Moore CM; Punwani S; van der Muelen J; Emberton M; Ahmed HU
J Urol; 2018 Dec; 200(6):1227-1234. PubMed ID: 30017964
[TBL] [Abstract][Full Text] [Related]
8. Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study.
Duwe G; Schmitteckert M; Haack M; Sparwasser P; Dotzauer R; Thomas A; Tsaur I; Brandt MP; Kurosch M; Mager R; Haferkamp A; Boehm K; Höfner T
World J Urol; 2024 May; 42(1):297. PubMed ID: 38709326
[TBL] [Abstract][Full Text] [Related]
9. A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk.
Miah S; Hosking-Jervis F; Connor MJ; Eldred-Evans D; Shah TT; Arya M; Barber N; Bhardwa J; Bott S; Burke D; Doherty A; Foster C; Freeman A; Hindley R; Jameson C; Karim O; Laniado M; Montgomery B; Nigam R; Punwani S; Sinclair A; Winkler M; Allen C; Ahmed HU
Eur Urol Oncol; 2020 Jun; 3(3):262-269. PubMed ID: 31411968
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial.
Boschheidgen M; Albers P; Schlemmer HP; Hellms S; Bonekamp D; Sauter A; Hadaschik B; Krilaviciute A; Radtke JP; Seibold P; Lakes J; Arsov C; Gschwend JE; Herkommer K; Makowski M; Kuczyk MA; Wacker F; Harke N; Debus J; Körber SA; Benner A; Kristiansen G; Giesel FL; Antoch G; Kaaks R; Becker N; Schimmöller L
Eur Urol; 2024 Feb; 85(2):105-111. PubMed ID: 37863727
[TBL] [Abstract][Full Text] [Related]
11. Added value of randomised biopsy to multiparametric magnetic resonance imaging-targeted biopsy of the prostate in a contemporary cohort.
Chaloupka M; Pyrgidis N; Ebner B; Volz Y; Pfitzinger PL; Berg E; Enzinger B; Atzler M; Ivanova T; Clevert DA; Buchner A; Stief CG; Apfelbeck M
BJU Int; 2024 May; 133(5):548-554. PubMed ID: 38060339
[TBL] [Abstract][Full Text] [Related]
12. The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification.
Hamid S; Donaldson IA; Hu Y; Rodell R; Villarini B; Bonmati E; Tranter P; Punwani S; Sidhu HS; Willis S; van der Meulen J; Hawkes D; McCartan N; Potyka I; Williams NR; Brew-Graves C; Freeman A; Moore CM; Barratt D; Emberton M; Ahmed HU
Eur Urol; 2019 May; 75(5):733-740. PubMed ID: 30527787
[TBL] [Abstract][Full Text] [Related]
13. Combined MRI-TRUS fusion targeted and systematic biopsy versus systematic biopsy alone for the detection of prostate cancer: protocol for a prospective single-centre trial.
Liu W; Kadier A; Shen D; He Y; Dong S; Zhu K; Xu G; Zhao B; Mao S; Guo C; Yao X; Wei Q; Han D; Yang B
BMJ Open; 2024 Mar; 14(3):e080593. PubMed ID: 38431292
[TBL] [Abstract][Full Text] [Related]
14. Role of targeted biopsy, perilesional biopsy, random biopsy, and their combination in the detection of clinically significant prostate cancer by mpMRI/transrectal ultrasonography fusion biopsy in confirmatory biopsy during active surveillance program.
Novara G; Zattoni F; Zecchini G; Aceti A; Pellizzari A; Ferraioli G; Cobacchini C; Taverna A; Sattin F; Carletti F; La Bombarda G; Lacognata CS; Lauro A; Gardiman M; Morlacco A; Betto G; Dal Moro F
Prostate Cancer Prostatic Dis; 2024 Mar; 27(1):129-135. PubMed ID: 37828151
[TBL] [Abstract][Full Text] [Related]
15. MRI in-bore biopsy following MRI/US fusion-guided biopsy in patients with persistent suspicion of clinically significant prostate cancer.
Quentin M; Boschheidgen M; Radtke JP; Spohn F; Ullrich T; Drewes L; Valentin B; Lakes J; Al-Monajjed ; Arsov C; Esposito I; Albers P; Antoch G; Schimmöller L
Eur J Radiol; 2024 Jun; 175():111436. PubMed ID: 38522396
[TBL] [Abstract][Full Text] [Related]
16. The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients.
Postema AW; Scheltema MJ; Mannaerts CK; Van Sloun RJ; Idzenga T; Mischi M; Engelbrecht MR; De la Rosette JJ; Wijkstra H
BMC Urol; 2017 Apr; 17(1):27. PubMed ID: 28381220
[TBL] [Abstract][Full Text] [Related]
17. Role of targeted biopsy, perilesional biopsy, and random biopsy in prostate cancer diagnosis by mpMRI/transrectal ultrasonography fusion biopsy.
Novara G; Zattoni F; Zecchini G; Aceti A; Pellizzari A; Ferraioli G; Carlesso M; La Bombarda G; Morlacco A; Lacognata CS; Lauro A; Gardiman M; Betto G; Zanovello N; Moro FD
World J Urol; 2023 Nov; 41(11):3239-3247. PubMed ID: 37079076
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of regional systematic biopsy for prostate cancer stratified by PI-RADS and histologic zones.
Sun Z; Liu Y; Yu W; Wang H; Shen Q; Zhang C
Insights Imaging; 2024 May; 15(1):118. PubMed ID: 38755502
[TBL] [Abstract][Full Text] [Related]
19. MRI-Targeted, Systematic, or Combined Biopsy for Detecting Clinically Significant Prostate Cancer.
Burk KS; Naik S; Lacson R; Tuncali K; Lee LK; Tempany C; Cole AP; Trinh QD; Kibel AS; Khorasani R
J Am Coll Radiol; 2023 Jul; 20(7):687-695. PubMed ID: 37315913
[TBL] [Abstract][Full Text] [Related]
20. Comparative diagnostic accuracy of multiparametric magnetic resonance imaging-ultrasound fusion-guided biopsy
Fang JH; Zhang L; Xie X; Zhao P; Bao L; Kong F
PeerJ; 2023; 11():e16614. PubMed ID: 38107582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]